jego samoistnej eliminacji dzięki działaniu ukł. odpornościowego – można wspomóc to działanie immunomodulacją. Np. stosowanie pranobexu inozyny bardzo dobrze stymuluje aktywność ukł. odpornościowego w celu pozbycia się HPV w przypadkach zmian szyjki macicy
Inosine pranobex "has been licensed for the treatment of cell-mediated immunodeficiency associated with human papillomavirus (HPV), herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV)." https://t.c
RT @renesugar: A Review on Inosine Pranobex Immunotherapy for Cervical HPV-Positive Patients https://t.co/cLYaaNpNMi
https://t.co/cLYaaNpNMi "Most of the 21 healthy patients undergoing daily administration of 4 g IP in a Bulgarian study presented with rapid immune responses, increases in the numbers of their lymphocytes, and circadian fluctuation of these parameters in
https://t.co/cLYaaNpNMi "B lymphocyte transformation may be a response to IP action but also a consequence of the effects of IP on macrophages and T helper cells." "IP stimulates certain immune mediators, promotes Th1 cells, and inhibits Th2 cells."
https://t.co/cLYaaNpNMi "3) molecular reorganization and a nearly threefold increase in the density of intramembrane plasma particles (IMP)." "The humoral immune response consists of activating B lymphocyte transformation into plasma cells and initiating
https://t.co/cLYaaNpNMi "IP suppresses the synthesis and translational ability of lymphocyte mRNA and inhibits viral RNA synthesis by:" "1) inosine-mediated inclusion of orotic acid in polyribosomes;" "2) suppression of polyadenylic acid capture by vira
https://t.co/cLYaaNpNMi "NK activity in eosinophils rises in response to increases in the numbers of lgG and complement-surface markers as well as macrophage, monocyte, and neutrophil chemotaxis and phagocytosis."
https://t.co/cLYaaNpNMi "Moreover, IP downregulates other anti-inflammatory cytokines and may block their effects on the immune response." "IP administration increases the number and activity of natural killer cells (NK)."
https://t.co/cLYaaNpNMi "Lymphocyte stimulation with IP upregulated IL-2, interferon γ (IFN-γ),and tumor necrosis factor alpha (TNF-a) and downregulated IL-4, IL-5, and IL-10." "IFN-γ expression and IP block IL-10 production."
https://t.co/cLYaaNpNMi "Certain studies investigated the influences of IP on Th1- and Th2-related cytokines." "When the lymphocytes were at rest, the cytokine levels remained constant."
https://t.co/cLYaaNpNMi "Similarly, IP modulates T lymphocyte and natural killer cell cytotoxicity and T8 suppressor and T4 helper cell function and increases the numbers of immunoglobulin G (IgG) and complement-surface markers."
https://t.co/cLYaaNpNMi "Induction of IL-2 and IFN-γ activates T lymphocyte maturation and differentiation and the lymphoproliferative response."
https://t.co/cLYaaNpNMi "IP stimulates a Th1 cell response characterized by proinflammatory cytokine (IL-2 and IFN-γ) upregulation in mitogen- and antigen-activated cells."
https://t.co/cLYaaNpfWK "IAD has immunomodulatory and antiviral properties and is registered in numerous countries under the brand names Immunovir, Isoprinosine, Viruxan, Inosiplex, Methisoprinol, and Inosine Pranobex."
https://t.co/cLYaaNpNMi "Inosine acedobendimepranol (IAD) is a synthetic purine derivative consisting of a 3:1 ratio of p-acetamidobenzoic acid salt of N,N-dimethyl-amino-2-propanol (DiP.PAcBA) and the β polymorph of the β anomer of inosine."
https://t.co/cLYaaNpNMi "Since 1971, IP has been licensed for the treatment of cell-mediated immunodeficiency associated with human papillomavirus (HPV), herpes simplex virus (HSV), varicella-zoster virus (VZV), cytomegalovirus (CMV), and Epstein-Barr vir
https://t.co/cLYaaNpNMi "Inosine pranobex (IP), also known as inosine acedobendimepranol (INN) or methisoprinol, is an antiviral drug consisting of a 1:3 ratio of inosine and dimepranolacedoben." "The latter is a salt of acetamidobenzoic acid and dimethy
https://t.co/cLYaaNpNMi "IP has antiviral efficacy because it modulates both cellular and humoral immunities. IP has been on the market since 1971."
https://t.co/cLYaaNpNMi "The purpose of this review was to examine and summarize data for inosine pranobex (IP) immunotherapy in cervical HPV-positive patients."
A Review on Inosine Pranobex Immunotherapy for Cervical HPV-Positive Patients https://t.co/cLYaaNpNMi
A Review on Inosine Pranobex Immunotherapy for Cervical HPV-Positive Patients https://t.co/jyIV85QRxQ